SEC 13F Intelligence

Matarin Capital Management, LLC / HTD

Matarin Capital Management, LLC’s Corcept Therapeutics Inc Position

Does Matarin Capital Management, LLC own Corcept Therapeutics Inc (HTD)? Yes — 239.7K shares worth $6M (+1.53% of its 13F portfolio) as of Q4 2020, down from 410.3K shares the prior filed quarter.

Position Value
$6M
Q4 2020
Shares
239.7K
% of Portfolio
+1.53%
Quarters Held
8
currently held

Position History HTD

Reported value by quarter
Q4 ’18: $1.3BQ4 ’18Q1 ’19: $3MQ1 ’19Q2 ’19: $8MQ2 ’19Q3 ’19: $13MQ3 ’19Q4 ’19: $8MQ4 ’19Q1 ’20: $7MQ1 ’20Q2 ’20: $7MQ2 ’20Q4 ’20: $6MQ4 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2020239.7K$6M+1.53%
Q2 2020410.3K$7M+1.38%
Q1 2020623.9K$7M+1.15%
Q4 2019650.3K$8M+0.75%
Q3 2019891.6K$13M+0.95%
Q2 2019730.2K$8M+0.58%
Q1 2019263.4K$3M+0.22%
Q4 2018100.0K$1.3B+0.11%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Matarin Capital Management, LLC’s full portfolio or all institutional holders of HTD.